Evaluation of cardiovascular risk in the hypertensive patient: Comparison between scores;La valutazione del rischio cardiovascolare nel paziente iperteso: Confronto tra score

Italian Heart Journal, Supplementi

Volumn 5, Issue 9, 2004, Pages 694-704

  Del Colle, Sara ^a   Rabbia, Franco ^a   Mulatero, Paolo ^a   Veglio, Franco ^a  

^a Ospedale San Vito   (Italy)

Author keywords

Guidelines; Hypertension; Risk factors

Indexed keywords

ALGORITHM; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; EVALUATION; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ALGORITHMS; CARDIOVASCULAR DISEASES; EVALUATION STUDIES; HUMANS; HYPERTENSION; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS;

EID: 16644370861     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA 1996; 275: 1571-6.
2. Klang MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-8.
3. Nesbitt SD, Julius S. Prehypertension: a possible target for antihypertensive medication. Curr Hypertens Rep 2000; 2: 356-61.
4. Kannel WB, Wilson WF. Hypertension as a cardiovascular risk factor. In: Bulpitt CJ, ed. Handbook of hypertension. Epidemiology of hypertension. Amsterdam: Elsevier Science, 2000: 19-42.
5. Ramsay LE, Wallis EJ, Yeo WW, Jackson PR. Absolute and relative risk in hypertension. In: Bulpitt CJ, ed. Handbook of hypertension. Epidemiology of hypertension. Amsterdam: Elsevier Science, 2000: 43-56.
6. Chobanian VA, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
7. Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
8. Whitworth JA, for the World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-92.
9. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth Working Party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139-85.
10. Wilson PW, D'Agostino R, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47. (Pubitemid 28213628)
11. Wolf PA, D'Agostino R, Belanger AM, Silbershatz H, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke 1991; 22: 312-8.
12. Kannel WB, D'Agostino R, Silbershatz H, Belanger AM, Wilson PW, Levy D. Profile for estimating risk of heart failure. Arch Intern Med 1999; 159: 1197-204. (Pubitemid 29269859)
13. Batujii-Garin S, Deverly A, Moyse D, et al, on behalf of the INSIGHT Committees and Investigators. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens 2002; 20: 1973-80.
14. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham study. Stroke 1994; 25: 40-3.
15. Ambrosioni E, Mancia G, Agabiti Rosei E, Leonetti G, Trimarco B, Volpe M. The Forlife Study. Synopsis of the study protocol. High Blood Press 2003; 10: 91-3.
16. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP, on behalf of the INDANA Project Steering Committee. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001; 323: 75-81.
17. Conroy RM, Pyorala K, Fitgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
18. Atlante italiano delle malattie cardiovascolari. II edizione 2004. Il Progetto CUORE - Studi longitudinali. Ital Heart J 2004; 5 (Suppl 3): 94S-101S.
19. Assmann G. Lipid metabolism disorders and coronary heart disease: primary prevention, diagnosis and therapy: guidelines for general practice. 2nd edition. Munchen: MMV-Medizin-Verl, 1993.
20. Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999; 81: 40-6.
21. Tunstall-Pedoe H. The Dundee coronary risk-disk for management of change in risk factors. BMJ 1991; 303: 744-7.
22. Shaper AG, Pocock SJ, Phillips AN, Walker M. Identifying men at high risk of heart attacks: strategy for use in general practice. BMJ 1986; 293: 474-9. (Pubitemid 16051218)
23. Yikona JINM, Wallis EJ, Ramsay LE, Jackson PR. Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods. J Hypertens 2002; 20: 2173-82.
24. Wallis EJ, Ramsay LE, Haq IU, et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish Health Survey population. BMJ 2000; 320: 671-6.
25. Wood D, Durrington P, Poulter N, Mclnnes G, Rees A, Wray R, on behalf of the British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society and endorsed by the British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80 (Suppl): S1-S29.
26. Ministry of Health. Guidelines for the management of mildly raised blood pressure in New Zealand. Wellington: Core Services Committee, Ministry of Health, 1995.
27. Guidelines Subcommittee. World Health Organisation-International Society of Hypertension guidelines for management of hypertension. J Hypertens 1999; 17: 151-83.
28. The sixth report of the Joint National Committee on Detection, Prevention, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-46.
29. Persson M, Carlberg B, Weinehall L, Nilsson L, Stegmayn B, Lindholm LH. Risk stratification by guidelines compared with risk assessment by risk equations applied to a MONICA sample. J Hypertens 2003; 21: 1089-95. (Pubitemid 36667862)
30. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105-14.
31. D'Agostino RB, Grundy S, Sullivan LM, Wilson P, for the CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286: 180-7.